Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Groarke

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Cancer Medicine|December 23, 2018
Case-control study of heart rate abnormalities across the breast cancer survivorship continuumJohn D Groarke, Syed S Mahmood, David Payne, et al.
JACC. Heart Failure|December 3, 2016
Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial PopulationsEmer Joyce, Anuradha Lala, Susanna R Stevens, et al.
European Heart Journal|January 3, 2018
Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fractionViviany R Taqueti, Scott D Solomon, Amil M Shah, et al.
ESC Heart Failure|December 21, 2021
Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrumJingyi Gong, Renata R T Castro, Jesse P Caron, et al.
Journal of the American College of Cardiology|September 28, 2019
Cardiovascular Toxicities Associated With IbrutinibJoe-Elie Salem, Ali Manouchehri, Marie Bretagne, et al.
ESC Heart Failure|March 12, 2021
Sex differences in congestive markers in patients hospitalized for acute heart failureCaroline Espersen, Ross T Campbell, Brian Claggett, et al.
JACC. Clinical Electrophysiology|December 22, 2018
Ibrutinib-Associated Atrial FibrillationSarju Ganatra, Ajay Sharma, Sachin Shah, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 14, 2020
Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancerJohn D Groarke, David L Payne, Brian Claggett, et al.
Journal of Cardiac Failure|February 5, 2016
Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHFJustin L Grodin, Anuradha Lala, Susanna R Stevens, et al.
ESC Heart Failure|April 15, 2025
Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fractionFawaz Naeem, Teresa C Leone, Christopher Petucci, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Cancer Medicine|December 23, 2018
Case-control study of heart rate abnormalities across the breast cancer survivorship continuumJohn D Groarke, Syed S Mahmood, David Payne, et al.
JACC. Heart Failure|December 3, 2016
Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial PopulationsEmer Joyce, Anuradha Lala, Susanna R Stevens, et al.
European Heart Journal|January 3, 2018
Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fractionViviany R Taqueti, Scott D Solomon, Amil M Shah, et al.
ESC Heart Failure|December 21, 2021
Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrumJingyi Gong, Renata R T Castro, Jesse P Caron, et al.
Journal of the American College of Cardiology|September 28, 2019
Cardiovascular Toxicities Associated With IbrutinibJoe-Elie Salem, Ali Manouchehri, Marie Bretagne, et al.
ESC Heart Failure|March 12, 2021
Sex differences in congestive markers in patients hospitalized for acute heart failureCaroline Espersen, Ross T Campbell, Brian Claggett, et al.
JACC. Clinical Electrophysiology|December 22, 2018
Ibrutinib-Associated Atrial FibrillationSarju Ganatra, Ajay Sharma, Sachin Shah, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 14, 2020
Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancerJohn D Groarke, David L Payne, Brian Claggett, et al.
Journal of Cardiac Failure|February 5, 2016
Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHFJustin L Grodin, Anuradha Lala, Susanna R Stevens, et al.
ESC Heart Failure|April 15, 2025
Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fractionFawaz Naeem, Teresa C Leone, Christopher Petucci, et al.
Pageof 6